Inferior vena cava filters in pulmonary embolism prevention

Česká verzia

Authors: V. Čížek; D. Kučera; M. Válka; P. Bartoš; D. Maděřič; M. Pleva
Authors place of work: Vaskulární centrum, Vítkovická nemocnice a. s., Ostrava, přednosta prim. MUDr. Dušan Kučera
Published in the journal: Vnitř Lék 2009; 55(3): 267-271
Category: 15th Parizek's Days

Summary

Pulmonary embolism (PE) is the most serious sign of venous thromboembolism and the 3rd most frequent cause of cardiovascular death. Therapy with anticoagulants represents, among other measures, the mainstay of PE treatment. However, anticoagulant therapy does not prevent recurrence of pulmonary embolism in 3–20% of patients. Most frequently, the source of pulmonary embolism is in venous circulation of lower limbs and pelvis. Interception of the inferior vena cava, originally surgical, later using inferior vena cava filters, is used as a preventive measure. Indications and contraindications of inferior vena cava filters have been redressed and modified several times; the paper provides their list. Older filters used to be retained within the inferior vena cava (so called permanent filters). This was one of the causes of relatively high incidence of complications related to the use of these filters, particularly venous thromboses, as confirmed by so far the only randomised study PREPIC. Consequently, retrievable filters that are currently preferred have been developed. The authors also provide an overview of studies in progress, describe the process of implantation and describe own patient group.

Key words:
pulmonary embolism prevention – inferior vena cava filter ligation, plication – inferior vena cava filter – permanent and retrievable filters – indications and contraindication

Zdroje

1. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1): 122–130.

2. Köcher M. Implantace filtrů do dolní duté žíly k prevenci plicní embolie. In: Krajina A, Peregrin JH. Intervenční radiologie. Praha: Galén 2005: 224–231.

3. Štverák P. Naše zkušenosti s implantací kaválního filtru TrapEase. Interv Akut Kardiol 2004; 3: 177–180.

4. Goldhaber SZ. Pulmonary embolism. Lancet 2004; 363: 1295–1305.

5. Mayzlík J. Chirurgické postupy při tromboembolismu. Bratisl Lek Listy 1997; 98: 459–483.

6. Eberlein TJ, Carey LC. Comparison of Surgical Managements for Pulmonary Emboli. Ann Surg 1974; 17: 836–841.

7. Comerota AJ. Retriavable IVC Filters: A Decision Matrix for Appropriate Utilization. Perspect Vasc Surg Endovasc Ther 2006; 18: 15–22.

8. Büller HR et al. Antithrombotic Therapy for Venous Thromboembolic Disease. Chest 2004; 126; 401S–428S.

9. Kiney TB. Update on inferior vena cava filters. J Vasc Interv Radiol 2003; 14: 425–440.

10. Ansell J. Vena Cava Filters. Do We Know All That We Need to Know? Circulation 2005; 112: 298–299.

11. Girard P, Decousus M et al. Diagnosis of PE in Patients with Proximal DVT. Am J Respir CritCare Med 2001; 164: 1033–1037.

12. Decousus H et al. Eight-Year Follow‑Up of Patients with Permanent Vena Cava Filters in the Prevention of PE. Circulation 2005; 112: 416–422.

13. Oliva VL et al. The Jonas Study: Evaluation of the Retrievability of the Cordis OptEase Inferior Vena Cava Filter. J Vasc Interv Rad 2005; 16: 1439–1445.

14. Ziegler JW et al. PROOF trial: protection from PE with the OptEase filter. J Vasc Interv Radiol 2008; 19: 1165–1167.

15. Greenfield LJ, Proctor MC. Suprarenal filter placement. J Vasc Surg 1998; 28: 432–438.

16. Grassi CJ et al. Quality Improvement Guidelines for Permanent IVC Filter Placement. J Vasc Interv Radiol 2003; 14: S271–S275.

17. Athanasoulis ChA et al. Inferior Vena Cava Filters: Review of a 26-year Single‑Center Clinical Experience. Radiology 2000; 216: 54–66.

18. Kaufman JA, Kinney TB et al. Guidelines for the use of retrievable vena cava filters. J Vasc Interv Radiol 2006; 17: 449–459.